tiprankstipranks
Advertisement
Advertisement

PCRIVAN Stock Latest News

RIVANNA Builds Momentum With FDA-Cleared Imaging Platforms, AI Expansion, and New Growth Programs
Private CompaniesRIVANNA Builds Momentum With FDA-Cleared Imaging Platforms, AI Expansion, and New Growth Programs
1d ago
RIVAN
RIVANNA Gains Regional Recognition for Point-of-Care Imaging Innovation
PremiumPrivate Companies
RIVANNA Gains Regional Recognition for Point-of-Care Imaging Innovation
3d ago
RIVAN
RIVANNA Highlighted for Innovation in Clinical Decision-Support Imaging
PremiumPrivate Companies
RIVANNA Highlighted for Innovation in Clinical Decision-Support Imaging
3d ago
RIVAN
RIVANNA Highlights AI-Guided Anesthesia Platform and Expansion Cohort at DeviceTalks Boston
PremiumPrivate Companies
RIVANNA Highlights AI-Guided Anesthesia Platform and Expansion Cohort at DeviceTalks Boston
4d ago
RIVAN
RIVANNA Showcases AI-Guided Accuro 3S and Launches Expansion Programs at DeviceTalks Boston
PremiumPrivate Companies
RIVANNA Showcases AI-Guided Accuro 3S and Launches Expansion Programs at DeviceTalks Boston
4d ago
RIVAN
RIVANNA Builds Momentum as Accuro XV Clearance Draws Trade Press and Investor Attention
PremiumPrivate CompaniesRIVANNA Builds Momentum as Accuro XV Clearance Draws Trade Press and Investor Attention
8d ago
RIVAN
Media Coverage Builds Around RIVANNA’s Newly Cleared Accuro XV Imaging Platform
Premium
Private Companies
Media Coverage Builds Around RIVANNA’s Newly Cleared Accuro XV Imaging Platform
10d ago
RIVAN
RIVANNA’s Accuro XV Wins Trade Press Attention Following FDA 510(k) Clearance
Premium
Private Companies
RIVANNA’s Accuro XV Wins Trade Press Attention Following FDA 510(k) Clearance
10d ago
RIVAN
RIVANNA Highlights Regulatory Progress and Clinical Expansion in AI-Enabled MedTech
PremiumPrivate Companies
RIVANNA Highlights Regulatory Progress and Clinical Expansion in AI-Enabled MedTech
11d ago
RIVAN
RIVANNA Signals Regulatory and Clinical Momentum in AI-Driven MedTech
PremiumPrivate Companies
RIVANNA Signals Regulatory and Clinical Momentum in AI-Driven MedTech
11d ago
RIVAN
RIVANNA – Weekly Recap
PremiumPrivate Companies
RIVANNA – Weekly Recap
15d ago
RIVAN
FDA Clearance Positions RIVANNA’s Accuro XV for Musculoskeletal Imaging Expansion
PremiumPrivate Companies
FDA Clearance Positions RIVANNA’s Accuro XV for Musculoskeletal Imaging Expansion
17d ago
RIVAN
RIVANNA Secures FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound
PremiumPrivate CompaniesRIVANNA Secures FDA 510(k) Clearance for Accuro XV Musculoskeletal Ultrasound
17d ago
RIVAN
RIVANNA Secures FDA 510(k) Clearance for AI-Ready Accuro XV Musculoskeletal Ultrasound Platform
Premium
Private Companies
RIVANNA Secures FDA 510(k) Clearance for AI-Ready Accuro XV Musculoskeletal Ultrasound Platform
17d ago
RIVAN
RIVANNA’s MedTech Scale-Up Nomination Caps Year of Regulatory Wins and Clinical Expansion
Premium
Private Companies
RIVANNA’s MedTech Scale-Up Nomination Caps Year of Regulatory Wins and Clinical Expansion
19d ago
RIVAN
RIVANNA Gains Visibility With MedTech World Scale-Up Award Nomination
PremiumPrivate Companies
RIVANNA Gains Visibility With MedTech World Scale-Up Award Nomination
19d ago
RIVAN
RIVANNA Recognized as Scale-Up Award Nominee at MedTech World USA
PremiumPrivate Companies
RIVANNA Recognized as Scale-Up Award Nominee at MedTech World USA
19d ago
RIVAN
RIVANNA Highlights AI-Driven Advances in Neuraxial Anesthesia
PremiumPrivate Companies
RIVANNA Highlights AI-Driven Advances in Neuraxial Anesthesia
20d ago
RIVAN
RIVANNA Highlights Innovation Trends in Neuraxial Anesthesia
PremiumPrivate Companies
RIVANNA Highlights Innovation Trends in Neuraxial Anesthesia
20d ago
RIVAN
RIVANNA Highlights Accuro 3S Early Access and Data-Generation Strategy
PremiumPrivate CompaniesRIVANNA Highlights Accuro 3S Early Access and Data-Generation Strategy
22d ago
RIVAN
RIVANNA Highlights Early Access Expansion for Accuro 3S Anesthesia Platform
Premium
Private Companies
RIVANNA Highlights Early Access Expansion for Accuro 3S Anesthesia Platform
22d ago
RIVAN
RIVANNA Builds Momentum With AI-Guided Ultrasound Platforms and Expanding Clinical Evidence
Premium
Private Companies
RIVANNA Builds Momentum With AI-Guided Ultrasound Platforms and Expanding Clinical Evidence
22d ago
RIVAN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >